Navigation Links
Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
Date:8/27/2007

-Acquisition of Pacific Pharma Technologies Brings Proprietary Artificial Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to

Upstream-

-Initial Compounds Demonstrate Promising In Vitro Activity Against Devastating Parasitic Diseases Affecting 300 Million People Worldwide-

VANCOUVER, B.C., Aug. 27 /PRNewswire-FirstCall/ -- Upstream Biosciences Inc. (OTC Bulletin Board: UPBS) today announced it has completed the acquisition of Pacific Pharma Technologies Inc., an early stage biopharmaceutical company with a proprietary technology platform that combines artificial intelligence, advanced computational methods and chemical diversity techniques to discover new drugs. This technology has already generated novel compounds that in laboratory studies demonstrate both human and veterinary potential against major tropical parasitic diseases.

"This acquisition significantly broadens our strategic focus and provides Upstream with important new capabilities," said Joel L. Bellenson, Chief Executive Officer of Upstream. "We believe the innovative technology platform pioneered by Pacific Pharma may have substantial commercial potential in a number of therapeutic areas and it fits well with our existing core competencies in computational-based approaches to biomarker identification. Pacific Pharma has also generated novel compounds that have exhibited activity against targets relevant to cancer, the focus of our biomarker programs."

In screening studies in vitro, Pacific Pharma's lead compounds have demonstrated encouraging signs of efficacy against leishmaniasis and African sleeping sickness (trypanosomiasis). These parasites, which belong to a family of protozoa species that include Chagas disease and malaria, infect millions of individuals in Africa, South Asia and South America. Current treatments are often toxic, ineffective, inconvenient and expensive. In addition, recent reports document
'/>"/>

SOURCE Upstream Biosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
5. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
9. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
10. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...swire/ -- Celling Technologies, a subsidiary of Sp...nesis, Inc. to research potential applications for...ith acquired the global rights in spine for Tissue...echnology in November of 2007. Replacing the prio... Celling Technologies to further research adipose ...
(Date:11/9/2009)...RNewswire/ -- Women,s sexual health company, TivaM...eve as it prepares for a 2010 launch of its Viveve...Viveve is a name that we believe captures the esse..." said Kerry Pope, Viveve,s president and chief ex...lping women restore their sense of fulfillment and...
(Date:11/9/2009)...ewswire/ -- Access MediQuip, LLC, the nation,s fir...medical device management solutions to the healthc...g its corporate headquarters to Lake Mary, Florida...d growth, includes a major expansion of the Primer...anuary 2010 and relocation and expansion of the Ho...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 1Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 2Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 1Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 2BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 1BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 2BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 3BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 4
...itive Phase II Results of Roche and Ipsen,s First ...can Diabetes Association Meeting -, NUTLEY, N.J.,... diabetes drug taspoglutide (R1583) has been shown...ntrol and weight loss after only,eight weeks of tr...e that,supports entry into Phase III. Taspoglutide...
...AIN VIEW, Calif., June 9 Alexza,Pharmaceuticals, ...results,from its Phase 2a proof-of-concept clinica...tients with panic disorder. The study did not meet...of AZ-002 on the incidence of a,doxapram-induced p...on of a,doxapram-induced panic attack, both as com...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4
(Date:11/9/2009)...ion backs President Obama,s promise to not expand ... ,, Bishops still concerned for poor, elderly ...-- Cardinal Francis George of Chicago, president o..., lauded the November 7 decision of the U.S. House...eform money from paying for elective abortions. ,...
(Date:11/9/2009)...ports success with drugs that inhibit estrogen, ,...o drugs used to treat breast cancer and osteoporos...o a new study. , The drugs also cleared precanc...ted the onset of cancer in mice with precancerous ...nd the breast cancer/osteoporosis drug raloxifene ...
(Date:11/9/2009)...n and women almost equally, study finds, , ...y used clot-dissolving drug Plavix (clopidogrel) w...s of major clinical trials has found. , "After ...ing both men and women with this very important dr...ovascular thrombosis at New York University Langon...
(Date:11/9/2009)... Networking is everybody,s buzz word toda...StaffingClub.com enables Recruiters and Staffers c...nect, share, communicate and close positions. The ...heir profiles and network with recruiters. , ...rrent Job Market forces everyone to network more t...
(Date:11/9/2009)...ve letter formation could boost self-esteem, resea... News) -- Autistic children are more likely to hav...letters, than those without autism, researchers sa... to 13. Half of the study participants had autism ...within the normal range for perceptual reasoning o...
Breaking Medicine News(10 mins):Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2
...g 15 pounds or more over several years puts one at...are obese but maintain a stable weight . Resea... and 30 over 15 years. Most participants gained 15...s. But only 4 percent of those who didn't gain the...
...in optimum cardiovascular health can not only affe...rs .// Researchers say they have found a link ...or cognitive impairment in the elderly. The condit...ls of High Density Lipoprotein . During a span ...
...l tissue, which is normally found only in the lini... attaches itself to ligaments and organs in the ab...mptoms include pain, bleeding, inflammation, adhes...rs studied 133 women with endometriosis and a cont...
...ay be a strong link between Skin Allergies and can... may actually be more prone //to blood related can...ers reported this finding in a study in the recent...kemia and those of us who have as children suffer...
...ple researchers say dads who have children at an o...veloping schizophrenia later in life. Research...mitted to the hospital in Sweden between 1989 and ... conception and their children's risk of becoming ...
...s for viral RNA among organ and tissue donors who ...se // transmission among transplant recipients, sa...r the presence of blood antibodies to diseases suc...mune response. For the study 2,236 organ donors...
Other Medicine News:
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: